Clinical trial registry record

Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging

A registered PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase 3 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated December 9, 2015.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT01572025
Last registry update
December 9, 2015
Status
Completed
Phase
Phase 3
Sponsor
University of Nottingham
Enrollment
60
Countries
United Kingdom
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 3
Study design
RANDOMIZED · PARALLEL · TREATMENT · QUADRUPLE
Evidence population
Human clinical study registration
Participants
60
Population
FEMALE · 23 Years to 48 Years
Duration
2012-05-01 to 2014-12-01
Intervention
Dehydroepiandrosterone; Placebo
Comparator
Control
Outcomes measured
Number of oocytes retrieved — within 15 weeks after DHEA/Placebo supplementation; Feasibility to conduct a large multicentre randomised controlled trial — with in 20 weeks of the research period (per p…; Oocyte quality (clinical and molecular markers) — The sample is collected at 14-16 weeks after recruitment and assessme…; Aneuploidy rates in the immature oocytes and unfertilized oocytes using microarray technology — The sample is collected…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 3A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Ovarian ageing · 100%Title contains controlled term: ovarian aging. Source terminology contains: ovarian aging, ovarian reserve. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 35%. These figures help sort records; they are not medical ratings.

ovarian aging
Open primary sourceExport JSON